NCT04969211View on ClinicalTrials.gov

Bioequivalence Study Between VHX-896 Tablets and Iloperidone Tablets in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

June 30, 2021

Primary Completion Date

October 13, 2021

Study Completion Date

October 13, 2021

Conditions
Healthy
Interventions
DRUG

VHX-896 and iloperidone

oral tablet

DRUG

Iloperidone and VHX-896

oral tablet

Trial Locations (1)

65802

Vanda Investigational Site, Springfield

Sponsors
All Listed Sponsors
lead

Vanda Pharmaceuticals

INDUSTRY